Integrated Diagnostics Holdings plc
IDGXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $13,176 | $6,571 | $9,392 | $12,121 |
| - Cash | $1,188 | $674 | $649 | $891 |
| + Debt | $1,472 | $1,179 | $1,179 | $859 |
| Enterprise Value | $13,460 | $7,076 | $9,923 | $12,088 |
| Revenue | $5,720 | $4,123 | $3,605 | $5,225 |
| % Growth | 38.7% | 14.4% | -31% | – |
| Gross Profit | $2,182 | $1,524 | $1,462 | $2,804 |
| % Margin | 38.1% | 37% | 40.6% | 53.7% |
| EBITDA | $2,093 | $1,280 | $1,294 | $2,569 |
| % Margin | 36.6% | 31.1% | 35.9% | 49.2% |
| Net Income | $1,077 | $510 | $541 | $1,413 |
| % Margin | 18.8% | 12.4% | 15% | 27% |
| EPS Diluted | 1.82 | 0.85 | 0.9 | 2.35 |
| % Growth | 114.1% | -5.6% | -61.7% | – |
| Operating Cash Flow | $1,569 | $544 | $209 | $2,270 |
| Capital Expenditures | -$225 | -$326 | -$309 | -$264 |
| Free Cash Flow | $1,344 | $218 | -$100 | $2,006 |